Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2
NCT04655521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173
Last updated 2021-11-24
Summary
To evaluate host-immune biomarkers including TRAIL, IP-10, CRP and their computational integration for predicting COVID-19 and disease severity in patients with PCR-confirmed COVID-19.
Conditions
Sponsors & Collaborators
-
MeMed Diagnostics Ltd.
collaborator INDUSTRY -
Universität des Saarlandes
lead OTHER
Principal Investigators
-
Cihan Papan, MD · Universität des Saarlandes
Eligibility
- Min Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-02
- Primary Completion
- 2021-06-30
- Completion
- 2021-09-30
Countries
- Germany
Study Locations
More Related Trials
-
Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
NCT04429620 ·Status: UNKNOWN
-
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
NCT04446338 ·Status: UNKNOWN
-
International Study of Inflammation in COVID-19
NCT04818866 ·Status: COMPLETED
-
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
NCT04483908 ·Status: COMPLETED
-
SARS-CoV-2 IgG and IgM Serologic Assays
NCT04562246 ·Status: COMPLETED
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA
-
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
NCT04520880 ·Status: UNKNOWN
-
Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
NCT00001351 ·Status: ENROLLING_BY_INVITATION
-
COVID-19 Antibody and Reinfection Study
NCT05365750 ·Status: COMPLETED
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients
NCT04410471 ·Status: UNKNOWN
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002 ·Status: RECRUITING
-
Professional's Health in Epidemiological Crisis Covid-19
NCT04885478 ·Status: UNKNOWN
-
Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
NCT04945811 ·Status: COMPLETED ·Phase: NA
-
Seroconversion in COVID-19 Recovered Population
NCT04558385 ·Status: COMPLETED
-
Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population
NCT04568850 ·Status: UNKNOWN
-
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 ·Status: RECRUITING
-
A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
NCT06862531 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
NCT04579471 ·Status: RECRUITING
-
Autoimmunity Contributes to the Severe Progression of COVID-19
NCT04967781 ·Status: COMPLETED
-
Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)
NCT05459506 ·Status: UNKNOWN
-
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
NCT07251179 ·Status: NOT_YET_RECRUITING